Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 4 1

Status

Completed 42Unknown 21Terminated 13Active not recruiting 12Recruiting 9Withdrawn 8Not yet recruiting 5Enrolling by invitation 1

Sponsor Class

OTHER 5OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Gynecologic 1Gastrointestinal 1Classical hematology 1

Conditions

Venous Thromboembolism 1Pancreatic Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Multiple Myeloma 1Liver Cirrhosis 1Fibrosis 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 57pembrolizumab 55sintilimab 53Specimen Handling 53Surgical Procedures, Operative 52anlotinib 49Fluorouracil 49Magnetic Resonance Spectroscopy 48Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Aspirin × Clear all
NCT07529262 2026-04-14

AspiRe HCC

Curtin University

Phase 3 Not yet recruiting
890 enrolled

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Mayo Clinic

Phase 4 Not yet recruiting
25 enrolled
Gynecologic

Endometrial Neoplasms

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 3 Not yet recruiting
530 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT05637567 2023-11-13

ASAP

German Cancer Research Center

Phase 2 Not yet recruiting
170 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT06018688 2023-09-21

Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 2 Not yet recruiting
44 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡